Difference between revisions of "Li-Fraumeni syndrome"

Li-Fraumeni syndrome (view source)

4 bytes added , 01:01, 8 September 2011

m

w

48,830

edits

Revision as of 20:18, 19 March 2011 (view source) Michael (talk \| contribs) (more) ← Older edit		Revision as of 01:01, 8 September 2011 (view source) Michael (talk \| contribs) m (w) Newer edit →
Line 1:		Line 1:
	'''Li-Fraumeni syndrome''' is due to germline mutations in the gene TP53 (p53),<ref>{{OMIM\|191170}}</ref> an important regulator of apoptosis and the cell cycle, i.e. cell division. It is implicated in a very large number of sporadic cancer.		'''Li-Fraumeni syndrome''' is due to germline mutations in the gene TP53 (p53),<ref>{{OMIM\|191170}}</ref> an important regulator of [[apoptosis]] and the cell cycle, i.e. cell division. It is implicated in a very large number of sporadic cancer.

	Individuals with Li-Fraumeni syndrome are predisposed to cancer. TP53 is considered to be a tumour suppressor and like most tumour suppressors, inheritance is autosomal dominant.		Individuals with Li-Fraumeni syndrome are predisposed to cancer. TP53 is considered to be a tumour suppressor and like most tumour suppressors, inheritance is autosomal dominant.